-
Signature
-
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik
-
Stock symbol
-
LHX
-
Transactions as of
-
Jul 29, 2025
-
Transactions value $
-
-$8,771,760
-
Form type
-
4
-
Date filed
-
7/29/2025, 08:35 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| KUBASIK CHRISTOPHER E |
Chair and CEO, Director |
C/O L3HARRIS TECHNOLOGIES, INC., 1025 W. NASA BOULEVARD, MELBOURNE |
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik |
2025-07-29 |
0001194001 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LHX |
Common Stock, Par Value $1.00 |
Options Exercise |
$10.8M |
+72K |
+49.46% |
$149.31 |
218K |
Jul 29, 2025 |
Direct |
F1 |
| transaction |
LHX |
Common Stock, Par Value $1.00 |
Sale |
-$19.5M |
-72K |
-33.09% |
$271.14 |
146K |
Jul 29, 2025 |
Direct |
F2 |
| holding |
LHX |
Common Stock, Par Value $1.00 |
|
|
|
|
|
30K |
Jul 29, 2025 |
By grantor retained annuity trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
LHX |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-72K |
-64.21% |
$0.00 |
40.1K |
Jul 29, 2025 |
Common Stock, Par Value $1.00 |
72K |
$149.31 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: